Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with non-small cell lung cancer, small cell lung cancer, or limited stage small cell lung cancer (confirmed by tissue testing)
- People whose recommended treatment plan includes radiation therapy to the chest area, given at the same time as drug treatment (such as chemotherapy and/or immunotherapy), with or without additional drug treatment given before or after
- People aged 18 or older
- People who have a performance status score of 70 or above on the Karnofsky scale — this is a measure of how well a person is able to carry out daily activities (confirm with trial site)
- People who are willing and able to sign a consent form agreeing to take part
- People who are willing to complete a 6-minute walking test
- People who are willing to have a heart marker blood test as part of the study assessments
Who may not be able to join:
- People who are unable or unwilling to sign a written consent form
- People who have previously had radiation therapy to the chest in an area that overlaps with the planned treatment area for this trial
- People who are pregnant or breastfeeding
- People with kidney failure that requires dialysis
- People who are unwilling to complete the tests required by the study protocol
- People for whom any of the required study tests are medically not suitable (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhongxing Liao, MD, M.D. Anderson Cancer Center
Phone: 832-829-5312
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Increase in level of hs-TnT >= 5ng/L; Incidence of grade >= 2 cardiovascular events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.